Donald Trump is a populist.
That means he sometimes takes positions that upset establishment Republicans.
Now Paul Ryan is picking a fight with Donald Trump on behalf of the donor class.
In his last press conferences, Donald Trump expressed his desire to bring down the cost of prescription drugs.
He felt “Big Pharma” companies were ripping off the American people with their high prescription drug prices.
Trump expressed his desire to reform the bidding process for these prescription drugs.
“Trump promised during his press conference in New York City at Trump Tower last week to reform the pharmaceutical industry to ensure proper bidding procedures take place—among other reforms to the major industry—moving forward.
“We have to get our drug industry coming back,” Trump said at the press conference. “Our drug industry has been disastrous. They’re leaving left and right. They supply our drugs but they don’t make them here, to a large extent. And the other thing we have to do is create new bidding procedures for the drug industry, because they’re getting away with murder. Pharma has a lot of lobbies, a lot of lobbyists, a lot of power. And there’s very little bidding on drugs. We’re the largest buyer of drugs in the world, and yet we don’t bid properly. We’re going to start bidding. We’re going to save billions of dollars over a period of time.”
Later, in an interview with the Washington Post, Trump doubled down on his criticisms of Big Pharma. “They’re politically protected, but not anymore,” Trump said in that interview of drug companies.
Trump’s comments sent the pharmaceutical industry, according to Fortune Magazine, into a financial tailspin. So naturally, Ryan–the donor class’s representative in Washington–rode into the rescue and to fight Trump.”
Paul Ryan responded and took up for the Pharmaceutical industry.
Breitbart also reports:
Trump’s comments sent the pharmaceutical industry, according to Fortune Magazine, into a financial tailspin. So naturally, Ryan–the donor class’s representative in Washington–rode into the rescue and to fight Trump.
Ryan, in response in an interview with Mike Allen of Axios, said that he wants to “have more conversations about” Trump’s efforts to crack down on Big Pharma corruption before the president-elect—soon to be president—does so.
“I believe that the current premium support system with Part D works extremely well,” Ryan said. “I think there’s some real success stories … and I think we need to tell that story.”
When asked by Allen if that also means telling such stories to Trump, he replied that the story needs to be told to “a lot of people.”
“I think [incoming Health and Human Services Secretary] Tom Price understands this issue extremely well,” Ryan said.
When asked specifically about Trump’s Washington Post comments about how the drug companies are “politically protected, but not anymore” under Trump’s administration, Ryan replied: “I don’t speak like that, generally speaking. I’m always looking for win-win situations, and I believe there’s a lot more we can do to bring down the price of drugs.”
This wouldn’t be the first disagreement between Ryan and Trump.
Trump’s populist platform includes deporting illegal immigrants, building a wall to secure our Southern borders, canceling globalist trade deals that strip the middle class of their ability to achieve the American dream, and a more restrained “America First” foreign policy.
Ryan – who sits in Washington as the avatar for the donor class – opposes all of these proposals.
He backs open borders, amnesty, international trade agreements like the Trans-Pacific Partnership, and an interventionist foreign policy.
There are some issues such as repealing Obamacare, tax cuts, and rolling back Obama’s job-killing regulations where Trump and the GOP congress will work hand-in-glove.
But on Trump’s populist proposals, Ryan appears ready to fight on behalf the establishment donor class.